• Gijs Ijpma, Linda Kachmar, Oleg S Matusovsky, Jason H T Bates, Andrea Benedetti, James G Martin, and Anne-Marie Lauzon.
• 1 Meakins-Christie Laboratories.
• Am. J. Respir. Crit. Care Med.. 2015 Apr 15;191(8):884-93.

RationaleAirway smooth muscle (ASM) plays a key role in airway hyperresponsiveness (AHR) but it is unclear whether its contractility is intrinsically changed in asthma.ObjectivesTo investigate whether key parameters of ASM contractility are altered in subjects with asthma.MethodsHuman trachea and main bronchi were dissected free of epithelium and connective tissues and suspended in a force-length measurement set-up. After equilibration each tissue underwent a series of protocols to assess its methacholine dose-response relationship, shortening velocity, and response to length oscillations equivalent to tidal breathing and deep inspirations.Measurements And Main ResultsMain bronchi and tracheal ASM were significantly hyposensitive in subjects with asthma compared with control subjects. Trachea and main bronchi did not show significant differences in reactivity to methacholine and unloaded tissue shortening velocity (Vmax) compared with control subjects. There were no significant differences in responses to deep inspiration, with or without superimposed tidal breathing oscillations. No significant correlations were found between age, body mass index, or sex and sensitivity, reactivity, or Vmax.ConclusionsOur data show that, in contrast to some animal models of AHR, human tracheal and main bronchial smooth muscle contractility is not increased in asthma. Specifically, our results indicate that it is highly unlikely that ASM half-maximum effective concentration (EC50) or Vmax contribute to AHR in asthma, but, because of high variability, we cannot conclude whether or not asthmatic ASM is hyperreactive.

22 keywords...

hide…